Showing results (11-20 of 19) with videos related to
Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 19 results.
Life Sciences|May 13, 2023
Montelukast prevents mice against carbon tetrachloride- and methionine-choline deficient diet-induced liver fibrosis: Reducing hepatic stellate cell activation and inflammationShiyun Pu, Jingyi Zhang, Changyu Ren, et al.Foods (Basel, Switzerland)|August 14, 2025
Postharvest Application of <i>Myo</i>-Inositol Extends the Shelf-Life of Banana Fruit by Delaying Ethylene Biosynthesis and Improving Antioxidant ActivityLingyu Hu, Yi Li, Kun Zhou, et al.Journal of Translational Medicine|August 7, 2024
TCF12-regulated GRB7 facilitates the HER2+ breast cancer progression by activating Notch1 signaling pathwayGang Wang, Yuanli Wu, Yue Su, et al.British Journal of Pharmacology|January 29, 2025
SGK3 promotes estrogen receptor-positive breast cancer proliferation by activating STAT3/ZMIZ2 pathway to stabilise β-cateninLie Yuan, Yongqing Cai, Gang Wang, et al.Biochemical Pharmacology|June 9, 2024
INPP4B suppresses HER2-induced mesenchymal transition in HER2+ breast cancer and enhances sensitivity to LapatinibNa Qu, Gang Wang, Yue Su, et al.Biochemical Pharmacology|June 8, 2023
VPS34-IN1 induces apoptosis of ER+ breast cancer cells via activating PERK/ATF4/CHOP pathwayQiuya Wu, Duanfang Zhou, Zhengze Shen, et al.European Journal of Pharmacology|July 10, 2023
N76-1, a novel CDK7 inhibitor, exhibits potent anti-cancer effects in triple negative breast cancerLimei Zhang, Lihong Wu, Duanfang Zhou, et al.Neoplasia (New York, N.Y.)|April 19, 2025
Activation of PERK/eIF2α/ATF4 signaling inhibits ERα expression in breast cancerYuanli Wu, Gang Wang, Ruixue Yang, et al.Biochemical Pharmacology|January 29, 2024
CCT020312 exerts anti-prostate cancer effect by inducing G1 cell cycle arrest, apoptosis and autophagy through activation of PERK/eIF2α/ATF4/CHOP signalingDuanfang Zhou, Manjialan Yin, Baoguo Kang, et al.Pageof 2